ストックスクリーナーアプリを入手
1.94
19.83%
-0.48
アフターアワーズ：
1.89
-0.05
-2.58%
前日終値:
$2.42
開ける：
$2.35
24時間の取引高:
8.05M
Relative Volume:
1.21
時価総額：
$43.63M
収益：
$2.05M
当期純損益:
$-23.15M
株価収益率:
-0.2925
EPS:
-6.6319
ネットキャッシュフロー:
$-16.93M
1週間 パフォーマンス:
+61.67%
1か月 パフォーマンス:
+55.20%
6か月 パフォーマンス:
+88.35%
1年 パフォーマンス:
-22.71%
1日の値動き範囲:
$1.83
$2.375
1週間の範囲:
$1.54
$3.82
52週間の値動き範囲:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
IBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.94 | 54.42M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 開始されました | Oppenheimer | Outperform |
| 2025-10-17 | 開始されました | Leerink Partners | Outperform |
| 2024-05-28 | 開始されました | Chardan Capital Markets | Buy |
| 2021-11-29 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-01-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 開始されました | Alliance Global Partners | Buy |
すべてを表示
iBio Inc (IBIO) 最新ニュース
Manufacturing Stocks To ResearchDecember 8th - MarketBeat
Best Penny Stocks To ConsiderDecember 10th - MarketBeat
iBio: Obesity Solutions to Drive Stock Momentum - StocksToTrade
Biotech Alert: Searches spiking for these stocks today - TipRanks
3 Penny Stocks to Watch Now, 12/9/25 - TipRanks
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025) - ts2.tech
Analyst Upgrade: Will iBio Inc stock outperform international peersQuarterly Trade Review & Accurate Intraday Trading Signals - moha.gov.vn
iBio Rockets: Is It a Mirage or Real Boost? - StocksToTrade
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
iBio’s New Approach: Game Changer or Just Artifice? - timothysykes.com
iBio (IBIO) Price Target Increased by 14.56% to 4.81 - Nasdaq
Can iBio Inc. stock sustain free cash flow growthJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Is iBio Inc. (0JV0) stock a fit for income portfoliosQuarterly Market Review & Daily Profit Maximizing Trade Tips - Newser
IBIO: Long-acting antibody pipeline targets obesity gaps, with IND filings and first-in-human trials ahead - TradingView — Track All Markets
Will iBio Inc. (0JV0) stock test record highs in 2025Weekly Risk Summary & Proven Capital Preservation Tips - Newser
IBIO: AI-driven antibody programs target obesity gaps with IND filings and first-in-human trials ahead - TradingView — Track All Markets
Can iBio Inc. stock deliver sustainable ROE2025 Volume Leaders & High Conviction Investment Ideas - Newser
How iBio Inc. stock reacts to oil pricesMarket Movement Recap & High Accuracy Swing Entry Alerts - Newser
Why iBio Inc. (0JV0) stock could rally strongly2025 Bull vs Bear & Safe Capital Growth Tips - Newser
Why iBio Inc. (0JV0) stock trades below fair valueLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How iBio Inc. (0JV0) stock responds to job market shiftsEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Why analysts raise outlook for iBio Inc. (0JV0) stockJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Aug Patterns: Should I hold or sell iBio Inc stock in 2025New Guidance & Proven Capital Preservation Tips - BỘ NỘI VỤ
iBio (IBIO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why retail traders accumulate iBio Inc. (0JV0) stockJuly 2025 Breakouts & Verified Entry Point Signals - Newser
How robust is iBio Inc. (0JV0) stock financial positionJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
Activity Recap: How institutional buying supports iBio Inc. stockJuly 2025 Final Week & AI Driven Stock Reports - moha.gov.vn
iBio, Inc. Reports Q3 2025 Financial Results - MSN
What technical charts say about iBio Inc. stockQuarterly Earnings Report & Long-Term Safe Investment Plans - moha.gov.vn
How institutional buying supports iBio Inc. stockPortfolio Gains Summary & Stepwise Trade Execution Plans - BỘ NỘI VỤ
iBio to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
[Form 4] iBio, Inc. Insider Trading Activity - Stock Titan
IBIO Form 4 shows director awarded 13,500 options at $1 - Stock Titan
IBIO Form 4: Director awarded 13,500 stock options at $1 - Stock Titan
iBio Form 4 shows director award of 13,500 stock options - Stock Titan
iBio shareholders elect directors and approve annual meeting proposals By Investing.com - Investing.com Canada
iBio Confirms Directors and Auditor at Annual Meeting - TipRanks
iBio shareholders elect directors and approve annual meeting proposals - Investing.com
[8-K] iBio, Inc. Reports Material Event | IBIO SEC FilingForm 8-K - Stock Titan
Can trapped investors hope for a rebound in iBio Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
iBio, Inc. (IBIO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Is iBio Inc. stock safe for conservative investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
Why hedge funds are buying iBio Inc. stockJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Will iBio Inc. stock deliver better than expected guidanceMarket Volume Summary & Stock Portfolio Risk Management - newser.com
Is iBio Inc. (0JV0) stock supported by free cash flowJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
Why iBio Inc. stock is rated strong buyTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
iBio Inc (IBIO) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):